Here's how it works:
The challenge for the next webinar
is to find ways to visualise not only responders, but also those who sustained
the response. The response is defined as 75%, 90% or 100% reduction in PASI
score. How to display sustained response? And what to do with missing data?
We’re looking forward seeing your
ideas on visualisations.
Further details can be found here.
Process & timeline:
| Dataset: Click here to download the data* | Dataset introduction: Webinar 14 from April 14th (available on VoD) |
| Submission: Click here to submit | Deadline: May 5th |
| Next webinar: Click here to register | Date: May 12th |
* NOTE to download a single data set as a csv file, click on the raw button and save the file. The following link describes the process in further detail
Register for...
The 2021 Monthly Webinars
Details of previous Wonderful Wednesdays can be found on our blog site. Each blog entry includes:
• Submitted visualisations
• A summary of the panel discussion
• Submitted code
Are you interested in learning more about the VIS SIG or to participate in the webinars?
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The field of data visualization is the intersection of data journalism, statistics, graphic design, computer science, neuroscience, and cognitive psychology. We will focus on the latter two fields of data visualization as it relates to data visualization: neuroscience and cognitive psychology.
Hear about potential strategies to handle non-proportional hazards and delayed treatment effects from experts in the field.
At this meeting we will present the evolution of missing data approaches, looking at how they have been handled in the past, the current established missing data approaches and the impact of the new ICH E9 R1 addendum on the handling of missing data, focussing in particular on the treatment policy estimand.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
The format of this event will include Ted Talks by all of our speakers with the opportunity for us to have a discussion together after each of the presentations.
A year on after the final ICH E9 estimands addendum was published, we bring estimands to life. Members of the Estimands in Oncology special interest group will describe how the estimand framework provides a common language to describe the diversity of patient journeys and why it is important to address the right question in clinical trials.
This course will cover the essentials of DMC set up (roles and responsibilities, DMC charter, practical considerations), as well as discussing DMC case studies and the role of DMCs in adaptive trials and during the pandemic. In addition, there will be an interactive DMC workshop.
As a statistician in the Biostatistics and Programming Department, you will be responsible for the methodological and statistical aspects of projects in early clinical development in order to optimize the early development plan and ensure its coherence.
As a Director of Statistics, you will be accountable for guiding statisticians in their work, performing senior review of documentation and output deliveries, providing oversight and advising on best practices approach to statistics for clinical trials.
This position provides expert statistical input and project management for statistical activities in relation to clinical trials and statistical activities executed by the Consumer Healthcare division
